Customer Letters

Please note: The following Customer Letters, do not replace the version that you receive from your local Canadian Blood Services site.

* The contents of the customer letters available on this site are current as of their dates of publication. If required, contact your local Hospital Liaison Specialist to determine if the letter is still current.

Displaying 1 - 19 of 19

	Date Sort ascending
CL_2019-19.pdf	2019-08-23	INFORMATION ONLY Summary of Results of 2019 Platelet Survey Customer Letter 2019-19 (PDF)
CL_2019-18.pdf	2019-08-12	INFORMATION ONLY Changes to Request Patient Designated Plasma Protein Products Customer Letter 2019-18 (PDF) \| Sample Request for Patient Designated Plasma Protein Products
CL 2019-17.pdf	2019-08-02	INFORMATION ONLY Launch of Hemlibra (emicizumub) Customer Letter 2019-17 (PDF) \| Hemlibra Product Profile \| Sample Request for Patient Designated Plasma Protein Products \| Dear Health Care Professionals letter
CL_2019-16.pdf	2019-07-31	INFORMATION ONLY Updates to Named Patient Program Customer Letter 2019-16 (PDF) \| Sample Request for Patient Designated Plasma Protein Products
CL_2019-15.pdf	2019-07-31	INFORMATION ONLY PANZYGA LOTS - Shelf Life Extension Customer Letter 2019-15 (PDF) \| PANZYGA LOTS– Shelf Life extension
CL_2019-14.pdf	2019-07-17	INFORMATION ONLY Gammagard Liquid Supply Customer Letter 2019-14 (PDF) \| Customer Letter from Takeda
CL_2019-13.pdf	2019-06-25	INFORMATION ONLY eProgesa Blood Component Label Change Customer Letter 2019-13 (PDF)
CL_2019-12.pdf	2019-06-17	INFORMATION ONLY Eloctate®, Alprolix® and Alternate Plasma Protein Product Requests Customer Letter 2019-12 (PDF) \| Sample Request for Alternate Plasma Protein Products \| Sample Request for Eloctate and Alprolix
CL_2019_11.pdf	2019-06-03	INFORMATION ONLY Use of fax emulating software solutions for Diagnostic Services Reports Customer Letter 2019-11 (PDF)
CL_2019-10.pdf	2019-05-22	INFORMATION ONLY Updates to Héma-Québec Component Codes and Héma-Québec Expiry Date of Irradiated Red Blood Cells Customer Letter 2019-10 (PDF)
CL_2019-09.pdf	2019-05-09	ACTION REQUIRED Cuvitru Supply Customer Letter 2019-09 (PDF) \| TAKEDA Cuvitru Supply
CL_2019-08.pdf	2019-05-08	ACTION REQUIRED Change to RiaSTAP® Storage Conditions Customer Letter 2019-08 (PDF) \| Change to RiaSTAP® Storage Conditions
CL_2019-07.pdf	2019-05-06	ACTION REQUIRED Resume Routine Fresenius Kabi Pooled Platelet Bag Inspections Customer Letter 2019-07 (PDF)
CL_2019-06.pdf	2019-04-29	INFORMATION ONLY Revision to Request: Patient Designated Plasma Protein Products Form Customer Letter 2019-06 (PDF) \| Request Patient Designated Plasma Protein Products
CL_2019-05.pdf	2019-04-18	ACTION REQUIRED Recombinant Factor VIII and IX Concentrates Contract Extensions and Product Availability (Further Information) Customer Letter 2019-05 (PDF)
CL_2019-04.pdf	2019-04-15	ACTION REQUIRED Recombinant Factor VIII and IX Concentrates Contract Extensions and Product Availability Customer Letter 2019-04 (PDF)
CL_2019-03.pdf	2019-04-11	ACTION REQUIRED Fresenius Kabi Platelet Bags Customer Letter 2019-03 (PDF) \| Fresenius Kabi - MEDICAL DEVICE RECALL
CL_2019-02.pdf	2019-03-05	ACTION REQUIRED Berinert® 1500IU Supply Customer Letter 2019-02 (PDF) \| CSL DCL Berinert 1500IU Supply
CL_2019-01.pdf	2019-02-04	ACTION REQUIRED Adynovate® approved by Health Canada for patients less than 12 years of age Customer Letter 2019-01 (PDF) \| Adyovate Pediatric Indication Approval